Pharma: Clinic Roundup
Thursday, July 18, 2013
Basilea Pharmaceutica Ltd., of Basel, Switzerland, said topline data from the SECURE and VITAL Phase III studies are on track to be available in the second half of 2013.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.